RNA
Avidity Biosciences Inc
Price:  
30.35 
USD
Volume:  
1,342,137.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Avidity EV/EBITDA

-260.2%
Upside

As of 2025-05-17, the EV/EBITDA ratio of Avidity Biosciences Inc (RNA) is -9.13. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. Avidity's latest enterprise value is 3,437.91 mil USD. Avidity's TTM EBITDA according to its financial statements is -376.41 mil USD. Dividing these 2 quantities gives us the above Avidity EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 11.3x - 13.4x 13.3x
Forward P/E multiples 18.2x - 29.1x 19.0x
Fair Price (54.89) - (40.09) (48.62)
Upside -280.9% - -232.1% -260.2%
30.35 USD
Stock Price
(48.62) USD
Fair Price

Avidity EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2025-05-15 -8.69
2025-05-14 -8.51
2025-05-13 -8.98
2025-05-12 -8.81
2025-05-09 -8.34
2025-05-08 -8.60
2025-05-07 -7.80
2025-05-06 -7.82
2025-05-05 -9.75
2025-05-02 -9.73
2025-05-01 -9.88
2025-04-30 -9.87
2025-04-29 -9.71
2025-04-28 -9.41
2025-04-25 -9.29
2025-04-24 -9.32
2025-04-23 -9.24
2025-04-22 -8.85
2025-04-21 -8.55
2025-04-17 -7.95
2025-04-16 -7.66
2025-04-15 -7.96
2025-04-14 -8.03
2025-04-11 -7.61
2025-04-10 -7.14
2025-04-09 -7.36
2025-04-08 -7.13
2025-04-07 -7.57
2025-04-04 -7.92
2025-04-03 -8.41
2025-04-02 -8.95
2025-04-01 -7.98
2025-03-31 -8.87
2025-03-28 -9.53
2025-03-27 -9.84
2025-03-26 -9.68
2025-03-25 -9.69
2025-03-24 -10.08
2025-03-21 -9.29
2025-03-20 -9.29
2025-03-19 -9.57
2025-03-18 -9.18
2025-03-17 -10.25
2025-03-14 -9.38
2025-03-13 -9.70
2025-03-12 -9.86
2025-03-11 -8.89
2025-03-10 -9.03
2025-03-07 -9.11
2025-03-06 -9.13